Milk protein shows promise in preventing deadly infections in preemies
NCT ID NCT07480434
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving a protein called lactoferrin (found in milk) to premature babies could help prevent sepsis, a severe infection. The trial included 180 preterm infants with low birth weight, who received lactoferrin or a placebo within 72 hours of birth. The goal was to see if this simple supplement could reduce the risk of sepsis in this vulnerable group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bovine lactoferrin (a protein from cow's milk)
What this could lead to
If it works, this could point toward a simple, safe way to reduce life-threatening infections in premature babies.
What could go wrong
This was a small, early-phase study (Phase 1) with only 180 participants. Results may not be conclusive, and larger trials are needed to confirm any benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Edward Medical University Lahore
Lahore, Punjab Province, 54000, Pakistan